Pourang Aunna, Sivamani Raja K
Department of Dermatology, University of California, Davis, Sacramento, CA Department of Biological Sciences, Davis, CA California State University, Sacramento, CA.
Dermatol Online J. 2019 Aug 15;25(8):13030/qt2q05z4rw.
Necrobiosis lipoidica is a chronic granulomatous disease of unknown etiopathogenesis, which is often difficult to treat. While data from randomized controlled trials for the treatment of necrobiosis lipoidica is lacking, several treatments of varying efficacy for necrobiosis lipoidica have been reported in the scientific literature. We present a case of a 29-year-old female with uncontrolled diabetes and treatment-resistant necrobiosis lipoidica which was responsive to ustekinumab.
类脂质渐进性坏死是一种病因发病机制不明的慢性肉芽肿性疾病,通常难以治疗。虽然缺乏治疗类脂质渐进性坏死的随机对照试验数据,但科学文献中已报道了几种对类脂质渐进性坏死疗效各异的治疗方法。我们报告一例29岁女性病例,该患者患有未得到控制的糖尿病且其难治性类脂质渐进性坏死对乌司奴单抗有反应。